Washington, DC (September 18, 2014) -- While dialysis can cause blood pressure changes that damage the brain, cooling dialysis fluids can protect against such effects. The findings come from a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The cooling intervention can be delivered without additional cost and is simple to perform.
While dialysis is an essential treatment for many patients with kidney disease, it can cause damage to multiple organs, including the brain and heart, due to the sudden removal of bodily fluids.
To characterize dialysis-induced brain injury and to see whether cooled dialysis fluids (called dialysate) might help reduce such injury, Christopher McIntyre, DM, and his colleagues randomized 73 new dialysis patients to dialyze with body temperature dialysate or dialysate cooled to 0.5◦C below body temperature for 1 year. (Dr. McIntyre was at the University of Nottingham in the UK while conducting this work but is now at the University of Western Ontario and the London Health Sciences Centre, in Canada.)
The study demonstrated that dialysis drives progressive white matter brain injury due to blood pressure instability; however, patients who dialyzed at 0.5◦C below body temperature were completely protected against such white matter changes.
"This study demonstrates that paying attention to improving the tolerability of dialysis treatment--in this case by the simple and safe intervention of reducing the temperature of dialysate--does not just make patients feel better, but also can completely protect the brain from progressive damage," said Dr. McIntyre.
- Dialysis drives progressive white matter brain injury due to blood pressure instability; however, patients who dialyzed at 0.5◦C below body temperature were completely protected against such white matter changes.
- Conventional dialysis can cause significant circulatory stress that damages multiple organs.
Study co-authors include Aghogho Odudu, MBChB, PhD and Mohamed Tarek Eldehni MD, MSc.
Disclosures: The study was funded by the UK National Institute of Health Research. Dr. McIntyre has received research funding and speaking honoraria from several dialysis companies (Fresenius, Baxter, Gambro, Braun).
The article, entitled "Randomized Clinical Trial of Dialysate Cooling and Its Effect on Brain White Matter," will appear online at http://jasn.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Founded in 1966, and with more than 14,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.